Open Forum Infectious Diseases
High Rate of Adverse Events in Patients Receiving Oral Antimicrobials under a COpAT Monitoring Protocol
By Ciara Sawey, Colleen Marie Burgoyne, Angelina K. Winbush and 3 others.
Abstract
Abstract We conducted a retrospective review to characterize adverse events (AEs) in patients receiving oral linezolid, trimethoprim-sulfamethoxazole, voriconazole, and itraconazole monitored under an outpatient parenteral antimicrobial therapy (OPAT) program. Among 118 patients, 61% incurred at least one AE during treatment, highlighting the need for evidence-based monitoring protocols for complex outpatient antimicrobial therapy (COpAT).
Keywords
- Antibiotics Pharmacokinetics and Efficacy
- Antimicrobial
- Adverse effect
- Protocol (science)
- Retrospective cohort study
- Itraconazole
- Antimicrobial stewardship
- MEDLINE
- Open access
Source
Published in Open Forum Infectious Diseases. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.